LORAMYC^® 50 mg, muco‐adhesive buccal tablets.

For more information, please refer to the Summary of Product Characteristics and patient leaflet: https://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69980852

Any report of an adverse reaction related to a Vectans Pharma drug should be made immediately by e-mail to infomed_pv@csp-epl.com.